ARGATROBAN IN 0.9% SODIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Argatroban In 0.9% Sodium Chloride, and what generic alternatives are available?
Argatroban In 0.9% Sodium Chloride is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in ARGATROBAN IN 0.9% SODIUM CHLORIDE is argatroban. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the argatroban profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Argatroban In 0.9% Sodium Chloride
A generic version of ARGATROBAN IN 0.9% SODIUM CHLORIDE was approved as argatroban by HIKMA PHARM CO LTD on January 5th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARGATROBAN IN 0.9% SODIUM CHLORIDE?
- What are the global sales for ARGATROBAN IN 0.9% SODIUM CHLORIDE?
- What is Average Wholesale Price for ARGATROBAN IN 0.9% SODIUM CHLORIDE?
Summary for ARGATROBAN IN 0.9% SODIUM CHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 34 |
| DailyMed Link: | ARGATROBAN IN 0.9% SODIUM CHLORIDE at DailyMed |
Recent Clinical Trials for ARGATROBAN IN 0.9% SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Veralox Therapeutics | Phase 2 |
| Veralox Therapeutics | Phase 1 |
| Celerion | Phase 1 |
US Patents and Regulatory Information for ARGATROBAN IN 0.9% SODIUM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | ARGATROBAN IN 0.9% SODIUM CHLORIDE | argatroban | INJECTABLE;INTRAVENOUS | 206769-001 | Dec 15, 2014 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
